State: New York

Qualifying Conditions

  • Amyotrophic Lateral Sclerosis (ALS)
  • Cancer
  • Chronic pain
  • Epilepsy
  • HIV/AIDS
  • Huntington's Disease
  • Inflammatory bowel disease
  • Parkinson's Disease
  • Post-Traumatic Stress Disorder
  • Multiple Sclerosis
  • Neuropathies
  • Spinal cord damage

Patient Possession Limits

As initially implemented, the law permits qualified patients to possess a 30-day supply of cannabis-infused, non-smokable products. Only non-smokable preparations allowed. Regulations announced by the Department of Health in 2017 states, "[R]egistered organizations will be allowed to manufacture and distribute additional products including topicals such as lotions, ointments and patches, as well as solid and semi-solid products including chewable and effervescent tablets and lozenges. Certain non-smokable forms of ground plant material will also be permissible for manufacture and distribution."

Home Cultivation

No

Caregiver Information

Yes, each certified patient may have up to two caregivers, and each caregiver may serve no more than five certified patients.

Reciprocity

No

Senate Bill 7047 authorizes the growth of industrial hemp to provide research for farmers and businesses. The Department of Agriculture & Markets and institutions of higher education can study the growth and cultivation of industrial hemp, provided that the sites are certified and registered with the Department of Agriculture & Markets. The sale and distribution of industrial hemp grown for such research is prohibited. Additionally, the commissioner can authorize up to ten sites for growing and cultivating industrial hemp. This law becomes effective date on June 15, 2015.

Source: http://norml.org/states/ny

New York.jpeg